Compare Stocks → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:EYEGNASDAQ:KZIAOTCMKTS:SEOVFNASDAQ:ZSAN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEYEGAB Corporate Bond ETF$35.28+0.5%$1.90$1.44▼$8.18$24.70M0.16935,975 shs5 shsKZIAKazia Therapeutics$0.27+3.9%$0.32$0.19▼$1.34$4.33M2.07594,428 shs60,120 shsSEOVFSernova$0.29+7.5%$0.31$0.21▼$0.83$86.47M1.221,626 shs15,703 shsZSANZosano Pharma$0.00$3.90$0.46▼$37.45$1K3.3425,375 shs5,685 shsThese 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEYEGAB Corporate Bond ETF+0.05%+0.05%+0.63%-0.45%+1,709.23%KZIAKazia Therapeutics+1.96%-5.08%-2.54%+20.50%-78.09%SEOVFSernova+7.02%+23.91%+1.79%-33.94%-53.82%ZSANZosano Pharma0.00%0.00%0.00%0.00%0.00%Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEYEGAB Corporate Bond ETFN/AN/AN/AN/AN/AN/AN/AN/AKZIAKazia Therapeutics0.749 of 5 stars0.05.00.00.02.10.01.3SEOVFSernova1.142 of 5 stars3.03.00.00.01.90.00.0ZSANZosano PharmaN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEYEGAB Corporate Bond ETFN/AN/AN/AN/AKZIAKazia TherapeuticsN/AN/AN/AN/ASEOVFSernova2.00Hold$1.50426.32% UpsideZSANZosano PharmaN/AN/AN/AN/ACurrent Analyst RatingsLatest ZSAN, SEOVF, EYEG, and KZIA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/4/2024SEOVFSernovaRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageMarket Perform$1.50(Data available from 6/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEYEGAB Corporate Bond ETF$10K2,469.60N/AN/A$1.26 per share28.00KZIAKazia Therapeutics$20K216.59N/AN/A$0.50 per share0.53SEOVFSernovaN/AN/AN/AN/A$0.03 per shareN/AZSANZosano Pharma$790K0.00N/AN/A$9.74 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEYEGAB Corporate Bond ETF-$8.09M-$1.68N/AN/AN/AN/A-104.96%-60.03%N/AKZIAKazia Therapeutics-$13.78MN/A0.00N/AN/AN/AN/AN/AN/ASEOVFSernova-$28.91M-$0.09N/A∞N/AN/A-226.64%-145.26%6/12/2024 (Estimated)ZSANZosano Pharma-$29.92M-$14.50N/A∞N/A-8,375.11%-177.06%-119.14%N/ALatest ZSAN, SEOVF, EYEG, and KZIA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/18/2024Q1 2024SEOVFSernovaN/A-$0.02-$0.02-$0.02N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEYEGAB Corporate Bond ETFN/AN/AN/AN/AN/AKZIAKazia TherapeuticsN/AN/AN/AN/AN/ASEOVFSernovaN/AN/AN/AN/AN/AZSANZosano PharmaN/AN/AN/AN/AN/ALatest ZSAN, SEOVF, EYEG, and KZIA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/31/2024EYEGAB Corporate Bond ETF$0.15396/3/20246/3/20246/6/20244/30/2024EYEGAB Corporate Bond ETFMonthly$0.14845/1/20245/2/20245/7/20243/28/2024EYEGAB Corporate Bond ETFMonthly$0.15724/1/20244/2/20244/5/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEYEGAB Corporate Bond ETF0.013.073.07KZIAKazia TherapeuticsN/A0.71N/ASEOVFSernova0.141.201.20ZSANZosano PharmaN/A1.611.61OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEYEGAB Corporate Bond ETF64.16%KZIAKazia Therapeutics30.89%SEOVFSernovaN/AZSANZosano PharmaN/AInsider OwnershipCompanyInsider OwnershipEYEGAB Corporate Bond ETF58.20%KZIAKazia Therapeutics1.00%SEOVFSernovaN/AZSANZosano Pharma2.40%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEYEGAB Corporate Bond ETF14700,0005.28 millionNot OptionableKZIAKazia Therapeutics2,02116.34 million16.18 millionOptionableSEOVFSernovaN/A303.41 millionN/ANot OptionableZSANZosano Pharma404.90 million4.78 millionNot OptionableZSAN, SEOVF, EYEG, and KZIA HeadlinesRecent News About These CompaniesApril 12, 2024 | seekingalpha.comHOOK HOOKIPA Pharma Inc.January 9, 2024 | wallstreet-online.deNachrichten - Weitere NachrichtenDecember 6, 2023 | pbs.orgLISTEN: Supreme Court hears arguments on legality of Purdue Pharma bankruptcy planAugust 22, 2023 | n-tv.deDer Börsen-Tag: Diese US-Aktie stürzte nachbörslich abMay 18, 2023 | bizjournals.comEast Bay Business NewsApril 27, 2023 | moneycontrol.comMankind Pharma IPO opens on April 25, listing scheduled for May 9April 6, 2023 | forbes.comAstellas PharmaFebruary 5, 2023 | finance.yahoo.comGiiant Pharma Receives Financial Support From the US Crohn’s and Colitis FoundationJanuary 23, 2023 | washingtonexaminer.comFTC asks court to hold 'pharma bro' Martin Shkreli in contempt for failing to abide by ordersNovember 5, 2022 | ca.finance.yahoo.comZosano Pharma Corporation (ZSANQ)October 13, 2022 | endpts.comNow bankrupt, Zosano sells off its drug delivery tech that once enticed Novo Nordisk, Eli LillyOctober 12, 2022 | msn.comBankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma GiantsAugust 28, 2022 | marketwatch.comBankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of ClaimsAugust 27, 2022 | bizjournals.comEast Bay migraine patch developer Zosano closes sale in bankruptcy court for $1 millionAugust 25, 2022 | investing.comZosano Pharma Corp (ZSANQ)July 26, 2022 | bizjournals.comEast Bay company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1MJuly 26, 2022 | bizjournals.comA Fremont company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M.June 3, 2022 | dbtnews.comZosano Pharma Corporation [ZSAN] stock Initiated by Maxim Group analyst, price target now $8June 2, 2022 | marketwatch.comZosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSANJune 2, 2022 | msn.comWhy Zosano Pharma Shares Are Getting Hammered TodayNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAB Corporate Bond ETFNASDAQ:EYEGEyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.Kazia TherapeuticsNASDAQ:KZIAKazia Therapeutics Limited operates as a biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma, diffuse intrinsic pontine glioma/advanced solid tumors, atypical teratoid rhabdoid tumor, brain metastases, triple negative breast cancer, and primary central nervous system lymphoma. It is also developing EVT801, a small molecule targeted therapeutic vascular endothelial growth factor receptor 3 inhibitor. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia.SernovaOTCMKTS:SEOVFSernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.Zosano PharmaNASDAQ:ZSANZosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.